De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Hacohen Y, Androdias G, Arrambide G, Bruijstens A L, Ciccarelli O, Cobo-Calvo A, Flanagan EP, Kim H J, Iacobaeus E, Lünemann JD, et al.